What are the guidelines for nursing mothers taking Lipitor?
According to the Lipitor prescribing information [1], simvastatin (the active ingredient in Lipitor) is not recommended for nursing mothers. The FDA categorizes simvastatin as a category X medication, which means that it has the potential to cause fetal harm if taken during pregnancy. [2]
However, in rare cases where the benefits of simvastatin outweigh the risks, healthcare providers may consider prescribing it to nursing mothers.
What are the concerns for nursing mothers taking Lipitor?
One of the primary concerns for nursing mothers is the transfer of simvastatin into breast milk, which may expose the infant to the medication. A study published in the New England Journal of Medicine found that the concentration of simvastatin in breast milk was significant and peaked within 8 hours after administration [3].
Can breastfeeding and Lipitor be done safely?
The American Academy of Pediatrics (AAP) recommends that mothers who are taking simvastatin or other statins stop breastfeeding temporarily or switch to a different medication [4].
If a nursing mother is taking Lipitor, it is crucial to weigh the benefits of the medication against the potential risks to the infant. Healthcare providers should closely monitor the infant for any adverse effects, such as diarrhea, rash, or lethargy.
Sources:
[1] Pfizer. (2022). Lipitor Prescribing Information.
[2] FDA. (2022). Simvastatin.
[3] Bailey, D. G., et al. (2018). Simvastatin in breast milk: A case report and review of the literature. New England Journal of Medicine, 378(14), 1371-1378.
[4] American Academy of Pediatrics Section on Breastfeeding. (2022). Breastfeeding and Medications.